Consumo de ivermectina, azitromicina y dexametasona en una botica privada de Trujillo, julio 2020-febrero 2021
No Thumbnail Available
Date
2021
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
El presente trabajo tuvo como objetivo evaluar el consumo de ivermectina, azitromicina y dexametasona en una botica privada de Trujillo, entre julio del 2020 y febrero del 2021, se utilizó la unidad técnica de medida Dosis Diaria Definida por cada mil habitantes día “DHD”, estos datos se obtuvieron del sistema de datos, se determinó la cantidad de unidades vendidas siendo el medicamento más dispensado dexametasona con 27300 unidades seguida por azitromicina con 10512, por último ivermectina con 1600, en los dos primeros la forma genérica tuvo una mayor demanda. La DHD mensual más alta fue de azitromicina con 0,84 seguido de 0,57 para ivermectina y 0,22 para dexametasona en todos los casos en el mes de julio. Además, se determinó que el costo mensual siendo el más alto para ivermectina similar con S/ 9600.00, para el caso de azitromicina el costo mensual más alto fue S/ 1212.00 y en dexametasona S/ 1560.00 ambos en presentación genérica, los tres durante el mes de julio. El costo total más alto fue para ivermectina seguido de dexametasona y por último azitromicina. Se evidencia una tendencia negativa en el consumo de los medicamentos estudiados, pero estas no son estadísticamente significativas a lo largo del estudio en ninguno de los tres casos; presentando un p= 0.2832 para ivermectina, p=0.1911 para azitromicina y p= 0.1523 para dexametasona.
ABSTRACT The objective of this work was to evaluate the consumption of ivermectin, azithromycin and dexamethasone in a private pharmacy in Trujillo, between July 2020 and February 2021, the technical unit of measurement of Defined Daily Dose per thousand inhabitants per day "DHD" was used. The data were obtained from the database, the number ofunits sold was determined, the most widely dispensed drug being dexamethasone with 27,300 units followed by azithromycin with 10,512 and finally ivermectin with 1,600, in the first two the generic form had a greater demand. The highest monthly DHD was for azithromycin with 0.84 followed by 0.57 for ivermectin and 0.22 for dexamethasone in all cases in the month of July. In addition, it was determined that the monthly cost being the highest for brand ivermectin with S / 9600.00, in the case of azithromycin the highest monthly cost was S / 1212.00 and for dexamethasone S / 1560.00 both in generic presentation the three during the month of July. The highest total cost was forivermectin followed by dexamethasone and finally azithromycin. There is evidence of a negative trend in the consumption of the studied drugs, but these are not statistically significant throughout the study in any of the three cases; presenting a p = 0.2832 for ivermectin, p = 0.1911 for azithromycin and p = 0.1523 for dexamethasone.
ABSTRACT The objective of this work was to evaluate the consumption of ivermectin, azithromycin and dexamethasone in a private pharmacy in Trujillo, between July 2020 and February 2021, the technical unit of measurement of Defined Daily Dose per thousand inhabitants per day "DHD" was used. The data were obtained from the database, the number ofunits sold was determined, the most widely dispensed drug being dexamethasone with 27,300 units followed by azithromycin with 10,512 and finally ivermectin with 1,600, in the first two the generic form had a greater demand. The highest monthly DHD was for azithromycin with 0.84 followed by 0.57 for ivermectin and 0.22 for dexamethasone in all cases in the month of July. In addition, it was determined that the monthly cost being the highest for brand ivermectin with S / 9600.00, in the case of azithromycin the highest monthly cost was S / 1212.00 and for dexamethasone S / 1560.00 both in generic presentation the three during the month of July. The highest total cost was forivermectin followed by dexamethasone and finally azithromycin. There is evidence of a negative trend in the consumption of the studied drugs, but these are not statistically significant throughout the study in any of the three cases; presenting a p = 0.2832 for ivermectin, p = 0.1911 for azithromycin and p = 0.1523 for dexamethasone.
Description
Keywords
consumo, ivermectina, azitromicina, dexametasona.